203 related articles for article (PubMed ID: 29855279)
21. PDK1 is a potential therapeutic target against angiosarcoma cells.
Wada M; Horinaka M; Yasuda S; Masuzawa M; Sakai T; Katoh N
J Dermatol Sci; 2015 Apr; 78(1):44-50. PubMed ID: 25726712
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel.
Isogai R; Kawada A; Aragane Y; Tezuka T
J Dermatol; 2004 Apr; 31(4):335-41. PubMed ID: 15187330
[TBL] [Abstract][Full Text] [Related]
23. Angiosarcoma of the gingiva: Metastasis from a primary tumor of the scalp.
Yang J; Mei K; Wu C; Wu Y; Xu Y
Indian J Dermatol Venereol Leprol; 2017; 83(5):626. PubMed ID: 27852985
[No Abstract] [Full Text] [Related]
24. Use of apatinib combined with pemetrexed for advanced ovarian cancer: A case report.
Sun H; Xiao M; Liu S; Shi R
Medicine (Baltimore); 2018 Jul; 97(27):e11036. PubMed ID: 29979376
[TBL] [Abstract][Full Text] [Related]
25. Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.
Hu X; Zhang J; Xu B; Jiang Z; Ragaz J; Tong Z; Zhang Q; Wang X; Feng J; Pang D; Fan M; Li J; Wang B; Wang Z; Zhang Q; Sun S; Liao C
Int J Cancer; 2014 Oct; 135(8):1961-9. PubMed ID: 24604288
[TBL] [Abstract][Full Text] [Related]
26. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
Li F; Zhu T; Cao B; Wang J; Liang L
Eur J Cancer; 2017 Oct; 84():184-192. PubMed ID: 28822888
[TBL] [Abstract][Full Text] [Related]
27. Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to Pazopanib.
Ravi V; Sanford EM; Wang WL; Ross JS; Ramesh N; Futreal A; Patel S; Stephens PJ; Miller VA; Ali SM
J Natl Compr Canc Netw; 2016 May; 14(5):499-502. PubMed ID: 27160228
[TBL] [Abstract][Full Text] [Related]
28. Apatinib and S-1 combination therapy for the treatment of advanced head and neck neoplasms: Three case reports.
Meng M; Ye X; Yang X; Huang G; Wei Z; Ni Y; Li W; Han X; Wang J
J Cancer Res Ther; 2019; 15(2):442-446. PubMed ID: 30964124
[TBL] [Abstract][Full Text] [Related]
29. Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.
Wang Y; Bi M; Zhang H; Gao Z; Zhou H; Chang S
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e528-e530. PubMed ID: 28028915
[TBL] [Abstract][Full Text] [Related]
30. Pazopanib can preserve cosmetic quality of life even in end-stage angiosarcoma.
Kitamura S; Hata H; Imafuku K; Haga N; Homma E; Shimizu H
Clin Exp Dermatol; 2015 Dec; 40(8):931-3. PubMed ID: 25817046
[No Abstract] [Full Text] [Related]
31. Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial.
Li J; Qin S; Xu J; Guo W; Xiong J; Bai Y; Sun G; Yang Y; Wang L; Xu N; Cheng Y; Wang Z; Zheng L; Tao M; Zhu X; Ji D; Liu X; Yu H
J Clin Oncol; 2013 Sep; 31(26):3219-25. PubMed ID: 23918952
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment.
Hoshina D; Abe R; Yoshioka N; Saito N; Hata H; Fujita Y; Aoyagi S; Shimizu H
J Dermatol Sci; 2013 May; 70(2):116-22. PubMed ID: 23522954
[TBL] [Abstract][Full Text] [Related]
33. Scalp angiosarcoma presented as skin-coloured papules.
Byun JY; Suhng EA; Cheong SH; Choi YW; Choi HY
Acta Derm Venereol; 2014 Jul; 94(4):461-2. PubMed ID: 24352247
[No Abstract] [Full Text] [Related]
34. Angiosarcoma of the scalp diagnosed by the presence of neck inflammation: a case report.
Karube R; Sasaki H; Shinozuka K; Fujisawa Y; Yanagawa T; Yamagata K; Onizawa K; Otsuka F; Bukawa H
Int J Oral Sci; 2012 Sep; 4(3):166-9. PubMed ID: 22699262
[TBL] [Abstract][Full Text] [Related]
35. Treatment of scalp angiosarcoma by controlled perfusion of A. carotis externa with pegylated liposomal doxorubicin and intralesional application of pegylated interferon alfa.
Bong AB; Bonnekoh B; Schön MP; Gollnick H
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):20-3. PubMed ID: 15692506
[TBL] [Abstract][Full Text] [Related]
36. Paradoxical antitumor effects of pazopanib in a cutaneous angiosarcoma patient.
Hoashi T; Hirabayashi M; Nakajima R; Takahashi N; Saeki H
J Dermatol; 2017 Sep; 44(9):1078-1079. PubMed ID: 27726177
[No Abstract] [Full Text] [Related]
37. Angiosarcoma of the face and scalp: effective systemic treatment in the older patient.
Letsa I; Benson C; Al-Muderis O; Judson I
J Geriatr Oncol; 2014 Jul; 5(3):276-80. PubMed ID: 24685486
[TBL] [Abstract][Full Text] [Related]
38. Apatinib, combined with chemotherapy or alone is effective in treating angiosarcoma: a case report.
Liu M; Liu Y; Guo H; Fu D; Lv L; Chen C; Li Y; Zhang W; Yao M; Zhao L
Anticancer Drugs; 2019 Aug; 30(7):e0738. PubMed ID: 31305298
[TBL] [Abstract][Full Text] [Related]
39. Complete remission in a patient with multifocal metastatic cutaneous angiosarcoma with a combination of paclitaxel and sorafenib.
Donghi D; Dummer R; Cozzio A
Br J Dermatol; 2010 Mar; 162(3):697-9. PubMed ID: 20030640
[No Abstract] [Full Text] [Related]
40. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
